broomeda

David T. Broome, MD, is a Clinical Assistant Professor of Medicine in the Metabolism, Endocrinology, and Diabetes (MEND) Division of the University of Michigan. Dr. Broome's clinical and research interests are in Type 1 Diabetes Mellitus and its prevention, Atypical Diabetes and Monogenic Diabetes (including MODY), and clinical trials.

Dr. Broome is dedicated to progress in scholarly work, translational research, and was the recipient of the Tait Endowed Research Scholarship for his work in diabetes in medical school, selected to the Clinical Scholars Program in residency, and several research and teaching awards thereafter, including: the Cleveland Clinic Foundation Endocrinology & Metabolism Institute Research Award, ENDO Experience Travel Award, the Cleveland Clinic Lerner College of Medicine Excellence in Teaching Award, the AACE Domestic Resident Travel Grant, the Michigan Clinical Trials Academy and the Caswell Diabetes Institute Clinical and Translational Scholars Program. Dr. Broome is currently the principal investigator of University of Michigan's MODY Registry, Co-Chairs the PRecision DIabetes ConsorTium (PREDICT; a multicenter academic MODY data sharing agreement), the PRECIDENTD clinical trial, the REMAIN-1 clinical trial, in addition to the Type 1 Diabetes Exchange.

He is also a co-investigator for the Rare and Atypical Diabetes Network (RADIANT), TrialNet and several clinical trials investigating the prevention of type 1 diabetes. He serves as a Review Editor on the editorial board for Frontiers in Clinical Diabetes and Healthcare and serves on the Editorial Board for the Journal of Clinical Endocrinology & Metabolism (JCEM).